National Academies Press: OpenBook

The Value of Genetic and Genomic Technologies: Workshop Summary (2010)

Chapter: Appendix A: Workshop Agenda

« Previous: References
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2010. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12947.
×

Appendix A
Workshop Agenda

The Value of Genetic and Genomic Technologies


The Beckman Center of the National Academies

100 Academy

Irvine, CA


March 22, 2010


MEETING OBJECTIVE


To examine the perceived value of genetic and genomic technologies, both present and future, in clinical practice

  • How do different stakeholders define the value of genetic and genomic technologies?

  • How do stakeholders evaluate the weight of one kind of value in relation to another?

  • How do people assess relative values to make health care decisions?

  • How do these types of values relate, or not relate, to the monetary cost of the technologies?

8:00–8:15 A.M.

PUBLIC WORKSHOP BEGINS—AUDITORIUM

8:00–8:15 A.M.

Welcome and Introductory Remarks

 

Wylie Burke, Roundtable Chair and Professor and Chair of the Department of Bioethics and Humanities, University of Washington

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2010. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12947.
×

8:15–10:15 A.M.

CORRELATIONBETWEEN LYNCH SYNDROMEAND COLON CANCER

8:15–8:30 A.M.

Case Study Presentation

 

Marc Williams, Director, Intermountain Healthcare Clinical Genetics Institute, LDS Hospital

8:30–9:00 A.M.

Lynch Syndrome Panelists

 

Mark Boguski, Associate Professor, Center for Biomedical Informatics, Harvard Medical School

Roy Gandolfi, Associate Medical Director, SelectHealth

Don Lyman, Chief, Chronic Disease and Injury Control Division, California Department of Public Health

Dennis Salisbury, Family Practice Physician, Rocky Mountain Clinic, Butte, MT

Andrew Spiegel, CEO, Colon Cancer Alliance

9:00–9:45 A.M.

Panel discussion

9:45–10:15 A.M.

Roundtable discussion

10:15–10:30 A.M.

BREAK

10:30–12:30 P.M.

PHARMACOGENOMIC TESTING FOR WARFARIN DOSING

10:30–10:45 A.M.

Case Study Presentation

 

David Veenstra, Associate Professor, Pharmaceutical Outcomes Research and Policy Program and Institute for Public Health Genetics, University of Washington

10:45–11:15 A.M.

Warfarin Panelists

 

Anna Garrett, Manager, Outpatient Clinical Pharmacy Programs, Mission Hospital, Asheville, NC

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2010. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12947.
×

 

Arthur Lurvey, Medical Director, Palmetto GBA

Elizabeth Mansfield, Director of the Personalized Medicine Staff, Office of In Vitro Diagnostic Devices, Center for Devices and Radiological Health, FDA

Dennis Salisbury, Family Practice Physician, Rocky Mountain Clinic, Butte, MT

11:15 A.M.–12:00 P.M.

Panel discussion

12:00–12:30 P.M.

Roundtable discussion

12:30–1:30 P.M.

LUNCH

1:30–4:00 P.M.

GENOMIC PROFILING

1:30–1:45 P.M.

Case Study Presentation

 

Bruce Blumberg, Co-Chief of Medical Genetics, Kaiser Permanente, Oakland and Institutional Director of Graduate Medical Education, Northern California Kaiser Permanente, The Permanente Medical Group

1:45–2:15 P.M.

Genomic Profiling Panelists

 

Karen Kaplan, Science Writer, Los Angeles Times

Vance Vanier, CEO and President, Navigenics

Janet Williams, Genetic Counselor, Intermountain Healthcare, Oncology Clinics

David Witt, Genetics Department, Kaiser San Jose Medical Center

Steven Woolf, Professor, Departments of Family Medicine, Epidemiology, and Community Health, Virginia Commonwealth University

2:15–3:15 P.M.

Panel discussion

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2010. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12947.
×

3:15–4:00 P.M.

Roundtable discussion

4:00–5:00 P.M.

SUMMARY

4:00–5:00 P.M.

Summary and wrap-up discussion

 

Bruce Blumberg, Co-Chief of Medical Genetics, Kaiser Permanente, Oakland and Institutional Director of Graduate Medical Education, Northern California Kaiser Permanente, The Permanente Medical Group

Wylie Burke, Roundtable Chair and Professor and Chair of the Department of Bioethics and Humanities, University of Washington

Catherine A. Wicklund, Director of the Graduate Program in Genetic Counseling and Assistant Professor, Department of Obstetrics and Gynecology, Northwestern University

Marc Williams, Director, Intermountain Healthcare Clinical Genetics Institute, LDS Hospital

5:00 P.M.

ADJOURN

Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2010. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12947.
×
Page 57
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2010. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12947.
×
Page 58
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2010. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12947.
×
Page 59
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2010. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12947.
×
Page 60
Next: Appendix B: Speaker Biographical Sketches »
The Value of Genetic and Genomic Technologies: Workshop Summary Get This Book
×
Buy Paperback | $40.00 Buy Ebook | $32.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!